Menu

All Activities

Find an Activity

Find an Activity

Find an Activity

Choose from the criteria below to find an activity that fits you best.

Attention Pharmacists and Pharmacy Techs: Click to access CPE Monitor and CE information More Information

Featured Activity

This activity will cover key topics of interest to stakeholders who set practice policy and will be called upon to evaluate and make decisions on issues pertaining to biosimilars.

Find an Activity

Find an Activity

Find an Activity

Choose from the criteria below to find an activity that fits you best.

SHOW SEARCH

Seeing through the Cloudiness: Antimicrobial Stewardship Initiatives for Asymptomatic Bacteriuria

Activity Downloads

To Participate

To participate in this continuing education activity:

  1. Review the activity description and objectives.
  2. View the activity.
  3. Complete the online post-test and activity evaluation.
A product of the Society of Infectious Diseases Pharmacists Education Center (SIDPEC) 

 
 View more SIDPEC Activities
 

Original Broadcast Date: Wednesday, October 12, 2016 Note: If you attended the live CE activity AND received CE credit (i.e. a pharmacist CE statement of credit with ACPE UAN 0221-9999-16-325-L01-P), you are NOT allowed to also receive credit for this home-study on-demand web activity.

Activity Description

This activity will discuss the appropriate use of antimicrobials for bacteriuria in the acute care setting. Differentiating when to treat and the consequences of inappropriate treatment will also be discussed. How antimicrobial stewardship programs and interventions play a role in this topic will also be addressed.

This is a featured CE activity on the Society of Infectious Diseases Pharmacists Education Center (SIDPEC) website. SIDPEC is the educational hub of the Society of Infectious Diseases Pharmacists (SIDP). The SIDPEC portal provides educational activities on infectious disease pharmacotherapy for clinical pharmacists, health‐systems pharmacists, community pharmacists, and other allied‐health disciplines.

Learning Objectives

At the conclusion of this activity, participants should be able to:

  • Discuss antimicrobial misuse and associated unintended consequences in the acute care setting.
  • Differentiate between asymptomatic bacteriuria (ASB) and urinary tract infection.
  • Describe antimicrobial stewardship interventions to minimize inappropriate antimicrobial use for ASB.

Faculty

Sarah M. Wieczorkiewicz, Pharm.D., BCPS AQ-ID
Clinical Pharmacist, Infectious Diseases
Director, PGY1 Residency Program
Advocate Lutheran General Hospital
Park Ridge, Illinois

Funding

No commercial funding was received for this activity.

CE Accreditation

Release Date: 10-12-2016
Expiration Date: 10-12-2019

Pharmacists:

APCE This CE activity is jointly provided by ProCE, Inc. and SIDP. ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-16-325-H01-P has been assigned to this knowledge-based home-study CE activity (initial release date 10-12-16). This CE activity is approved for 1.0 contact hour (0.1 CEU) in states that recognize ACPE providers. This CE activity is provided at no cost to participants. Successful completion of the online post-test and evaluation at www.ProCE.com is required to receive CE credit. CE credit will be uploaded to NABP/CPE Monitor. No partial credit will be given.

Disclosure

It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants any significant financial interest or affiliation with companies that manufacture or market products discussed in this activity. Dr. Wieczorkiewicz has no relevant commercial and/or financial relationships to disclose.

Please note: The information and views presented in this activity are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this activity may include the use of drugs and/or devices for unlabeled indications, which should be considered experimental. Participants are advised to consult manufacturer product information and the professional literature, and use professional judgment in applying the presented information in patient-care activities.

The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.